TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36254883

Group type: EXPERIMENTAL
Intervention: QMix as final irrigation protocol
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaOCl as final irrigation protocol
Number of subjects: 60
Study: 33900809

Group type: EXPERIMENTAL
Intervention: 90-second video intervention featuring a 22-year-old African American woman with schizophrenia
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Written vignette intervention containing the same material
Number of subjects: 1055

Group type: COMPARATOR
Intervention: Nonintervention control condition
Number of subjects: 1055
Study: 35971155

Group type: EXPERIMENTAL
Intervention: Usual care plus a personalised and pragmatic resistance exercise intervention for 12 weeks
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 220
Study: 32789516

Group type: EXPERIMENTAL
Intervention: 100 mg D-Cycloserine (DCS)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: 250 mg D-Cycloserine (DCS)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 33783470

Group type: EXPERIMENTAL
Intervention: 40 mg of oral atomoxetine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (26 subjects)
Number of subjects: 19
Study: 32424445

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 62
Study: 36064383

Group type: EXPERIMENTAL
Intervention: Multimodal chiropractic care
Number of subjects: 21
Study: 34487919

Group type: EXPERIMENTAL
Intervention: Carrageenan-containing gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study: 36125103

Group type: EXPERIMENTAL
Intervention: Simultaneous bleaching with 10% hydrogen peroxide for 2 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single arch bleaching with 10% hydrogen peroxide for 4 weeks
Number of subjects: 100
Study: 33349055

Group type: EXPERIMENTAL
Intervention: Attachment-Based Family Therapy (ABFT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 60
Study: 34254449

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 52
Study: 34155082

Group type: EXPERIMENTAL
Intervention: Oral fat‐based energy‐dense supplement (300 kcal daily) for 12 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Routine care for 12 weeks
Number of subjects: 240
Study: 34273598

Group type: EXPERIMENTAL
Intervention: TBI 300 cGy
Number of subjects: 179

Group type: COMPARATOR
Intervention: TBI 200 cGy
Number of subjects: 179
Study: 32663699

Group type: EXPERIMENTAL
Intervention: Activity scheduling (experimental group, n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n=50)
Number of subjects: 100
Study: 36123011

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once daily for 24 months
Number of subjects: 5112

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily for 24 months
Number of subjects: 5112

Group type: COMPARATOR
Intervention: Underweight category
Number of subjects: 5112

Group type: COMPARATOR
Intervention: Normal weight category
Number of subjects: 5112
Study: 34318392

Group type: EXPERIMENTAL
Intervention: #Tamojunto program
Number of subjects: 6391
Study: 33072352

Group type: EXPERIMENTAL
Intervention: Telegram-based education
Number of subjects: 64

Group type: COMPARATOR
Intervention: In-person education
Number of subjects: 64
Study: 616388350

Group type: EXPERIMENTAL
Intervention: Amlodipine/atorvastatin (Group 3)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Amlodipine (Group 2)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Hypotensor alone (Group 1)
Number of subjects: 144
Study: 35889926

Group type: EXPERIMENTAL
Intervention: Mo-enriched lettuce
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (lettuce)
Number of subjects: 24
Study: 34380344

Group type: EXPERIMENTAL
Intervention: Wii Fit Plus games
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 54
Study: 32376818

Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 79
Study: 35491577

Group type: EXPERIMENTAL
Intervention: Sensor balancing (SB)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Manual balancing (MB)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 250
Study: 34721416

Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus plantarum CCFM1143)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 55
Study: 34069479

Group type: EXPERIMENTAL
Intervention: Periodontitis (genetic liability)
Number of subjects: 2215

Group type: EXPERIMENTAL
Intervention: Periodontitis (validation SNPs)
Number of subjects: 2215

Group type: EXPERIMENTAL
Intervention: Parkinson’s disease (genetic liability)
Number of subjects: 2215
Study: 33353921

Group type: EXPERIMENTAL
Intervention: Lidocaine-Ketorolac (Li-KT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Lidocaine-Saline (Li-Saline)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups (Li-KT and Li-Saline)
Number of subjects: 88
Study: 35263421

Group type: EXPERIMENTAL
Intervention: Copper Intrauterine Device (Cu-IUD)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA-IM)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Levonorgestrel Implant (LNG-implant)
Number of subjects: 251

Group type: COMPARATOR
Intervention: HIV cases (n = 25)
Number of subjects: 251

Group type: COMPARATOR
Intervention: HIV controls (n = 100)
Number of subjects: 251
Study: 33689452

Group type: EXPERIMENTAL
Intervention: Virtual Reality Group (VRG) - virtual reality exercise (volleyball, Microsoft Xbox Kinect®, 3 days per week, 15 minutes per day) and cycling exercise for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Training Group (CTG) - aerobic exercise (cycling, 3 days per week, 20 minutes per day) and conventional exercises (muscle strengthening, balance, and flexibility, 3 days per week, 15 minutes per day) for 4 weeks
Number of subjects: 40
Study: 32301885

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 431
Study: 35325457

Group type: EXPERIMENTAL
Intervention: No accompanying person (March 2020)
Number of subjects: 872

Group type: COMPARATOR
Intervention: Control group 2 (February 2020)
Number of subjects: 872

Group type: COMPARATOR
Intervention: Control group 3 (March 2019)
Number of subjects: 872
Study: 34389579

Group type: EXPERIMENTAL
Intervention: CIME model (Community-delivered Integrated Malaria Elimination)
Number of subjects: 140

Group type: COMPARATOR
Intervention: ICMV (current model of care)
Number of subjects: 140
Study: 32779269

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study: 34111874

Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Diagnosis-specific cognitive behavioral therapy (dCBT)
Number of subjects: 291
Study: 33291974

Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention (YRI)
Number of subjects: 175
Study: 32064971

Group type: EXPERIMENTAL
Intervention: Extended-cycle regimen of combined oral contraceptive (ethinylestradiol 30μg and levonorgestrel 150μg)
Number of subjects: 1314

Group type: EXPERIMENTAL
Intervention: Extended-cycle regimen
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Conventional-cycle regimen
Number of subjects: 1314

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 1314
Study: 37142540

Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL (IGlar‐100)
Number of subjects: 2684
Study: 34404293

Group type: EXPERIMENTAL
Intervention: Peri-second ISI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Supra-second ISI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-frequency tones in supra-second ISI
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-frequency tones in supra-second ISI
Number of subjects: 30
Study: 34077057

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model (HBM)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 164
Study: 34021510

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise and health counselling
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70
Study: 32361332

Group type: EXPERIMENTAL
Intervention: Raman spectroscopy followed by chemometrics
Number of subjects: 0
Study: 35441666

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Befriending therapy
Number of subjects: 72
Study: 32468855

Group type: EXPERIMENTAL
Intervention: SPARK Precision
Number of subjects: 83

Group type: COMPARATOR
Intervention: SITA Standard
Number of subjects: 83
Study: 32723555

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI) using Evolut R device
Number of subjects: 290
Study: 35394462

Group type: EXPERIMENTAL
Intervention: Sensor-guided balancing device
Number of subjects: 130

Group type: COMPARATOR
Intervention: Freehand balancing technique
Number of subjects: 130
Study: 32652528

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg every 2 weeks (q2w)
Number of subjects: 772

Group type: COMPARATOR
Intervention: Secukinumab 300 mg every 4 weeks (q4w)
Number of subjects: 772
Study: 35258595

Group type: EXPERIMENTAL
Intervention: PnM + IStrSR group (perineal massage + instrument-assisted perineal stretching with short repeated protocol)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: PnM group (perineal massage)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: PnM + IStrLS group (perineal massage + instrument-assisted perineal stretching with long static protocol)
Number of subjects: 96

Group type: COMPARATOR
Intervention: IStrLS group (instrument-assisted perineal stretching with long static protocol)
Number of subjects: 96
Study: 33105246

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB) with 10ml of ropivacaine 1.0%
Number of subjects: 48

Group type: COMPARATOR
Intervention: Interscalene brachial plexus block (ISB) with 10ml of ropivacaine 1.0%
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Interscalene brachial plexus block (ISB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 33252406

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention delivered by trained Lay Health Advisors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34682331

Group type: EXPERIMENTAL
Intervention: Nutritional Guidance and Training Group (NTG)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Training Group (TG)
Number of subjects: 98
Study: 32184313

Group type: EXPERIMENTAL
Intervention: Oral melatonin (Circadin) 2 mg at night for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32879998

Group type: EXPERIMENTAL
Intervention: Cysteamine 5% cream
Number of subjects: 54

Group type: COMPARATOR
Intervention: Tranexamic Acid (TA) mesotherapy
Number of subjects: 54
Study: 32861897

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Patient education
Number of subjects: 320
Study: 33118052

Group type: EXPERIMENTAL
Intervention: Ayahuasca (single dose)
Number of subjects: 17
Study: 32901672

Group type: EXPERIMENTAL
Intervention: Oral aprepitant (80 mg), intravenous dexamethasone (8 mg), and palonosetron (0.075 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral placebo, intravenous dexamethasone (4 mg), and palonosetron (0.075 mg)
Number of subjects: 100
Study: 35025993

Group type: EXPERIMENTAL
Intervention: Olezarsen 10 mg every 4 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Olezarsen 15 mg every 2 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Olezarsen 10 mg every week
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Olezarsen 50 mg every 4 weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 114
Study: 34371824

Group type: EXPERIMENTAL
Intervention: Crocodile blood supplementation (CB) - 1 g day−1 for 18 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study: 36017797

Group type: EXPERIMENTAL
Intervention: Cladribine tablets (3.5 mg/kg)
Number of subjects: 968

Group type: COMPARATOR
Intervention: Placebo (after cladribine tablets)
Number of subjects: 968
Study: 33355258

Group type: EXPERIMENTAL
Intervention: Control-IQ closed-loop control (CLC) system
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 101
Study: 34180141

Group type: EXPERIMENTAL
Intervention: Combined Metabolic Activators (CMAs) including l-serine, N-acetyl-l-cysteine, nicotinamide riboside, and l-carnitine tartrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined Metabolic Activators (CMAs)
Number of subjects: 0
Study: 32007460

Group type: EXPERIMENTAL
Intervention: Mo.Ma Ultra device + Roadsaver stent (Mo.Ma + RS)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Mo.Ma Ultra device + Carotid Wallstent (Mo.Ma + CW)
Number of subjects: 104

Group type: COMPARATOR
Intervention: FilterWire device + Roadsaver stent (FW + RS)
Number of subjects: 104

Group type: COMPARATOR
Intervention: FilterWire device + Carotid Wallstent (FW + CW)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Carotid Wallstent (CW)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: All patients post-CAS
Number of subjects: 104
Study: 36163159

Group type: EXPERIMENTAL
Intervention: Neck/shoulder progressive exercise programme (20 min, 3×/week)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Health education sessions (60 min, 1×/week)
Number of subjects: 484
Study: 33096365

Group type: EXPERIMENTAL
Intervention: Take-home naloxone (THN) kits, including two doses of naloxone
Number of subjects: 22
Study: 35811182

Group type: EXPERIMENTAL
Intervention: Standard treatment plus home exercise program (ST+HEP)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 190
Study: 34354655

Group type: EXPERIMENTAL
Intervention: Goal-oriented self-management intervention
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control care
Number of subjects: 96
Study: 36384651

Group type: EXPERIMENTAL
Intervention: Whole Food Plant-Based (WFPB)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plant-Based Meat Alternatives (PBMA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Animal (omnivorous diet)
Number of subjects: 22
Study: 32195861

Group type: EXPERIMENTAL
Intervention: Antibiotic group (cephalexin 500 mg every 6 hours for 7 days)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo group (identical capsules)
Number of subjects: 124
Study: 35594693

Group type: COMPARATOR
Intervention: Diet LCPLME (low protein, low energy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet LCPHME (low protein, high energy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet HCPLME (high protein, low energy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet MCPLME (medium protein, low energy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet HCPHME (high protein, high energy)
Number of subjects: 40
Study: 34309926

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) algorithm for automatic classification of fetal occiput position using transperineal ultrasound (TPU) images.
Number of subjects: 1219
Study: 35997984

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34689142

Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: CO2 laser + AmF/NaF/SnCl2 solution
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (without treatment)
Number of subjects: 192

Group type: COMPARATOR
Intervention: AmF/NaF/SnCl2 solution
Number of subjects: 192
Study: 35151711

Group type: EXPERIMENTAL
Intervention: 22-gauge Franseen needles
Number of subjects: 523

Group type: COMPARATOR
Intervention: 22-gauge standard needles
Number of subjects: 523
Study: 34493253

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagery Rescripting (ImRs) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3-month SUD treatment only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous SUD/PTSD treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential SUD/PTSD treatment
Number of subjects: 0
Study: 32553435

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock-wave therapy (rESWT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ultrasound-guided low-dose intra-articular steroid injection (20 mg of triamcinolone acetonide)
Number of subjects: 103
Study: 35976544

Group type: EXPERIMENTAL
Intervention: UP-Caregiver (transdiagnostic intervention via telehealth)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed condition (6-weeks after receipt of psychoeducational materials)
Number of subjects: 80
Study: 34606752

Group type: EXPERIMENTAL
Intervention: story-based audiovisual mnemonics
Number of subjects: 80

Group type: COMPARATOR
Intervention: text-reading (control)
Number of subjects: 80
Study: 32865004

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg once daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 36216159

Group type: EXPERIMENTAL
Intervention: LASSO regression-based prediction equation for appendicular skeletal muscle mass (ASM)
Number of subjects: 1296

Group type: COMPARATOR
Intervention: BIA-measured ASM
Number of subjects: 1296
Study: 32609980

Group type: EXPERIMENTAL
Intervention: Amoxicillin (500 mg every 12 hours for 4 to <10 kg, 1000 mg every 12 hours for 10 to <14 kg, 1500 mg every 12 hours for 14 to <20 kg)
Number of subjects: 4002

Group type: COMPARATOR
Intervention: Placebo (matched volume)
Number of subjects: 4002

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 4002

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4002
Study: 33369213

Group type: EXPERIMENTAL
Intervention: Er:YAG laser technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional scalpel technique
Number of subjects: 40
Study: 35401752

Group type: EXPERIMENTAL
Intervention: Proxabrushes and regular toothbrushes
Number of subjects: 510

Group type: COMPARATOR
Intervention: Regular toothbrushes only
Number of subjects: 510
Study: 32250007

Group type: EXPERIMENTAL
Intervention: Whole-grain consumers
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Whole-grain intake
Number of subjects: 392
Study: 35854942

Group type: EXPERIMENTAL
Intervention: Multivoice chorus intervention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Simple psychological counseling
Number of subjects: 50
Study: 33864736

Group type: EXPERIMENTAL
Intervention: DS-Cav1 vaccine 50 μg with AlOH
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: DS-Cav1 vaccine 150 μg with AlOH
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: DS-Cav1 vaccine 500 μg with AlOH
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: DS-Cav1 vaccine (all doses)
Number of subjects: 95
Study: 34352922

Group type: EXPERIMENTAL
Intervention: Foley with concurrent prostaglandin (Foley-PGE)
Number of subjects: 2376

Group type: EXPERIMENTAL
Intervention: Foley only (Foley)
Number of subjects: 2376

Group type: EXPERIMENTAL
Intervention: Foley with concurrent oxytocin (Foley-oxytocin)
Number of subjects: 2376

Group type: COMPARATOR
Intervention: Prostaglandin only (PGE)
Number of subjects: 2376
Study: 34380538

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 207

Group type: COMPARATOR
Intervention: Meropenem
Number of subjects: 207
Study: 32629657

Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (nonoperative treatment)
Number of subjects: 0
Study: 34425924

Group type: EXPERIMENTAL
Intervention: Prolonged expressive writing (12 sessions)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard expressive writing (4 sessions)
Number of subjects: 112
Study: 33480569

Group type: EXPERIMENTAL
Intervention: Intravenous iopamidol at a dose of 480 mg iodine (I)/kg, sampled at 5 min, 1 hr, 6 hr, 24 hr, and 48 hr postinjection.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group received an equivalent volume of saline, sampled at 48 hr.
Number of subjects: 35
Study: 35640175

Group type: EXPERIMENTAL
Intervention: Muramyl peptides (200 micrograms administered intramuscularly daily for 7 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 60
Study: 32871947

Group type: EXPERIMENTAL
Intervention: High ligation, great saphenous vein stripping, and subfascial perforator vein surgery with sterilized electric pneumatic tourniquet and Esmarch's bandage
Number of subjects: 274

Group type: COMPARATOR
Intervention: Conventional method (control group)
Number of subjects: 274
Study: 35938325

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with conventional western medicine therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional western medicine therapy
Number of subjects: 60
Study: 32805324

Group type: EXPERIMENTAL
Intervention: Diabetic patients with MVD
Number of subjects: 2083

Group type: COMPARATOR
Intervention: Non-diabetic patients with MVD
Number of subjects: 2083

Group type: EXPERIMENTAL
Intervention: Diabetic patients with single vessel disease (SVD)
Number of subjects: 2083

Group type: COMPARATOR
Intervention: Non-diabetic patients with single vessel disease (SVD)
Number of subjects: 2083

Group type: EXPERIMENTAL
Intervention: Overall diabetic patients
Number of subjects: 2083

Group type: COMPARATOR
Intervention: Overall non-diabetic patients
Number of subjects: 2083
Study: 32221020

Group type: EXPERIMENTAL
Intervention: TROMP operation
Number of subjects: 208

Group type: COMPARATOR
Intervention: Conventional cytoreductive method
Number of subjects: 208
Study: 33633231

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine
Number of subjects: 46

Group type: COMPARATOR
Intervention: 0.25% levobupivacaine
Number of subjects: 46